Periodic Reporting for period 3 - EURE-CART (EURopean Endeavour for Chimeric Antigen Receptor Therapies)

The EURE-CART project aims to study adoptive immunotherapy with autologous T cells genetically modified with a tumor-reactive chimeric antigen receptor (CAR). CART cells specific for CD19 and BCMA, have received a conditional marketing authorization in EU and US, for the...